On August 18, 2020, Allurefeatured insights from AFAR expert Nir Barzilai, MD, highlighting how the field of geroscience is working to extend healthspan and lifespan to help us all live healthier for longer. The article spotlights therapeutics which target the biology of aging to extend health, such as Metformin which is the subject of the AFAR-managed TAME Trial.
Dr. Barzilai is AFAR's Scientific Director, a 1994 Glenn Foundation for Medical Research and AFAR Grants for Junior Faculty recipient, a 1997 Paul B. Beeson Emerging Leaders Center Development Award in Aging scholar, and a 2010 Irving S. Wright Award winner, as well as the Director at the Institute for Aging Research and distinguished Professor at the Albert Einstein College of Medicine.
Read the article, “Our Average Life Expectancy Could Increase to 115 Years Very Soon,” here.
